1. Home
  2. LGND vs KMPR Comparison

LGND vs KMPR Comparison

Compare LGND & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • KMPR
  • Stock Information
  • Founded
  • LGND 1987
  • KMPR 1990
  • Country
  • LGND United States
  • KMPR United States
  • Employees
  • LGND 68
  • KMPR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • KMPR Property-Casualty Insurers
  • Sector
  • LGND Health Care
  • KMPR Finance
  • Exchange
  • LGND Nasdaq
  • KMPR Nasdaq
  • Market Cap
  • LGND 3.2B
  • KMPR 3.4B
  • IPO Year
  • LGND 1992
  • KMPR N/A
  • Fundamental
  • Price
  • LGND $169.53
  • KMPR $52.98
  • Analyst Decision
  • LGND Strong Buy
  • KMPR Buy
  • Analyst Count
  • LGND 8
  • KMPR 4
  • Target Price
  • LGND $144.71
  • KMPR $67.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • KMPR 732.9K
  • Earning Date
  • LGND 08-05-2025
  • KMPR 10-29-2025
  • Dividend Yield
  • LGND N/A
  • KMPR 2.43%
  • EPS Growth
  • LGND N/A
  • KMPR 562.92
  • EPS
  • LGND N/A
  • KMPR 5.31
  • Revenue
  • LGND $181,488,000.00
  • KMPR $4,784,500,000.00
  • Revenue This Year
  • LGND $18.41
  • KMPR $0.77
  • Revenue Next Year
  • LGND $18.87
  • KMPR $6.74
  • P/E Ratio
  • LGND N/A
  • KMPR $9.90
  • Revenue Growth
  • LGND 53.40
  • KMPR 2.67
  • 52 Week Low
  • LGND $81.74
  • KMPR $45.02
  • 52 Week High
  • LGND $129.90
  • KMPR $73.01
  • Technical
  • Relative Strength Index (RSI)
  • LGND 72.58
  • KMPR 43.26
  • Support Level
  • LGND $161.82
  • KMPR $51.88
  • Resistance Level
  • LGND $169.00
  • KMPR $53.20
  • Average True Range (ATR)
  • LGND 3.90
  • KMPR 0.95
  • MACD
  • LGND -0.81
  • KMPR 0.13
  • Stochastic Oscillator
  • LGND 98.73
  • KMPR 40.76

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About KMPR Kemper Corporation

Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.

Share on Social Networks: